NYSE:CLB Core Laboratories (CLB) Stock Price, News & Analysis $18.90 0.00 (0.00%) (As of 11/1/2024 ET) Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends About Core Laboratories Stock (NYSE:CLB) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Core Laboratories alerts:Sign Up Key Stats Today's Range$18.75▼$19.3550-Day Range$16.52▼$20.1152-Week Range$13.82▼$25.13Volume260,108 shsAverage Volume430,101 shsMarket Capitalization$887.36 millionP/E Ratio29.08Dividend Yield0.21%Price Target$17.00Consensus RatingReduce Company OverviewCore Laboratories Inc. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and oil delivered products; and proprietary and joint industry studies, as well as services that support carbon capture, utilization and storage, geothermal projects, and the evaluation and appraisal of mining activities. The Production Enhancement segment provides services and products relating to reservoir well completions, perforations, stimulations, production, and well abandonment. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. The company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. Core Laboratories Inc. was founded in 1936 and is based in Houston, Texas.Read More… Nvidia warning urgent (Ad)I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. Here’s the full story for you. Core Laboratories Stock Analysis - MarketRank™See Top Rated MarketRank™ Stocks27th Percentile Overall ScoreCLB MarketRank™: Core Laboratories scored higher than 27% of companies evaluated by MarketBeat, and ranked 229th out of 263 stocks in the oils/energy sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion0.8 / 5Analyst RatingReduce Consensus RatingCore Laboratories has received a consensus rating of Reduce. The company's average rating score is 1.50, and is based on no buy ratings, 2 hold ratings, and 2 sell ratings.Amount of Analyst CoverageCore Laboratories has only been the subject of 1 research reports in the past 90 days.Read more about Core Laboratories' stock forecast and price target. Earnings and Valuation2.5 / 5Proj. Earnings Growth36.36% Earnings GrowthEarnings for Core Laboratories are expected to grow by 36.36% in the coming year, from $0.77 to $1.05 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Core Laboratories is 29.08, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 128.03.Price to Earnings Ratio vs. SectorThe P/E ratio of Core Laboratories is 29.08, which means that it is trading at a more expensive P/E ratio than the Oils/Energy sector average P/E ratio of about 12.50.Price to Earnings Growth RatioCore Laboratories has a PEG Ratio of 1.34. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioCore Laboratories has a P/B Ratio of 3.46. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Core Laboratories' valuation and earnings. Short Interest0.0 / 5Short Interest LevelBearish Percentage of Shares Shorted15.04% of the float of Core Laboratories has been sold short.Short Interest Ratio / Days to CoverCore Laboratories has a short interest ratio ("days to cover") of 17.5, which indicates bearish sentiment.Change versus previous monthShort interest in Core Laboratories has recently increased by 1.90%, indicating that investor sentiment is decreasing. Dividend1.7 / 5Dividend StrengthWeak Dividend YieldCore Laboratories has a dividend yield of 0.21%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthCore Laboratories does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Core Laboratories is 6.15%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Core Laboratories will have a dividend payout ratio of 3.81% next year. This indicates that Core Laboratories will be able to sustain or increase its dividend.Read more about Core Laboratories' dividend. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted15.04% of the float of Core Laboratories has been sold short.Short Interest Ratio / Days to CoverCore Laboratories has a short interest ratio ("days to cover") of 17.5, which indicates bearish sentiment.Change versus previous monthShort interest in Core Laboratories has recently increased by 1.90%, indicating that investor sentiment is decreasing. News and Social Media3.1 / 5News Sentiment0.56 News SentimentCore Laboratories has a news sentiment score of 0.56. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.44 average news sentiment score of Oils/Energy companies.News Coverage This WeekMarketBeat has tracked 5 news articles for Core Laboratories this week, compared to 3 articles on an average week.Search InterestOnly 2 people have searched for CLB on MarketBeat in the last 30 days. This is a decrease of -33% compared to the previous 30 days.MarketBeat Follows1 people have added Core Laboratories to their MarketBeat watchlist in the last 30 days. Company Ownership1.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Core Laboratories insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 0.76% of the stock of Core Laboratories is held by insiders.Percentage Held by Institutions97.81% of the stock of Core Laboratories is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Core Laboratories' insider trading history. Receive CLB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Core Laboratories and its competitors with MarketBeat's FREE daily newsletter. Email Address CLB Stock News HeadlinesCore Laboratories (NYSE:CLB) Rating Increased to Hold at StockNews.comOctober 31 at 3:55 AM | americanbankingnews.comEvercore ISI Remains a Hold on Core Laboratories (CLB)October 26, 2024 | markets.businessinsider.comNvidia warning urgentI thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. November 2, 2024 | Porter & Company (Ad)Core Laboratories Inc (CLB) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid ...October 25, 2024 | finance.yahoo.comCore Laboratories (CLB) Q3 2024 Earnings Call TranscriptOctober 25, 2024 | msn.comCore Laboratories reports Q3 ex-items EPS 25c, consensus 23cOctober 24, 2024 | markets.businessinsider.comCore Laboratories Reports Strong Q3 2024 Financial GrowthOctober 24, 2024 | markets.businessinsider.comCORE LAB REPORTS THIRD QUARTER 2024 RESULTSOctober 23, 2024 | prnewswire.comSee More Headlines CLB Stock Analysis - Frequently Asked Questions How have CLB shares performed this year? Core Laboratories' stock was trading at $17.66 at the beginning of 2024. Since then, CLB shares have increased by 7.0% and is now trading at $18.90. View the best growth stocks for 2024 here. How were Core Laboratories' earnings last quarter? Core Laboratories Inc. (NYSE:CLB) announced its earnings results on Wednesday, October, 23rd. The oil and gas company reported $0.25 EPS for the quarter, topping analysts' consensus estimates of $0.21 by $0.04. The company's revenue was up 7.2% on a year-over-year basis. Who are Core Laboratories' major shareholders? Core Laboratories' top institutional shareholders include Boston Trust Walden Corp (1.28%), Van ECK Associates Corp (0.89%), Principal Financial Group Inc. (0.47%) and Confluence Investment Management LLC (0.29%). View institutional ownership trends. How do I buy shares of Core Laboratories? Shares of CLB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Core Laboratories own? Based on aggregate information from My MarketBeat watchlists, some other companies that Core Laboratories investors own include Humana (HUM), American Water Works (AWK), Waste Connections (WCN), Voyager Therapeutics (VYGR), The RMR Group (RMR), AUO (AUOTY) and DiamondRock Hospitality (DRH). Company Calendar Ex-Dividend for 8/26 Dividend8/05/2024Dividend Payable8/26/2024Last Earnings10/23/2024Today11/02/2024Ex-Dividend for 11/25 Dividend11/04/2024Dividend Payable11/25/2024Fiscal Year End12/31/2024Next Earnings (Estimated)1/29/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorOils/Energy Industry Oil & gas field services, not elsewhere classified Sub-IndustryPetroleum And Natural Gas Current SymbolNYSE:CLB CUSIPN/A CIK1000229 Webwww.corelab.com Phone(713) 328-2673FaxN/AEmployees3,600Year Founded1936Price Target and Rating Average Stock Price Target$17.00 High Stock Price Target$22.00 Low Stock Price Target$14.00 Potential Upside/Downside-10.0%Consensus RatingReduce Rating Score (0-4)1.50 Research Coverage4 Analysts Profitability EPS (Most Recent Fiscal Year)$0.65 Trailing P/E Ratio29.06 Forward P/E Ratio24.53 P/E Growth1.34Net Income$36.67 million Net Margins5.83% Pretax Margin8.72% Return on Equity15.84% Return on Assets6.47% Debt Debt-to-Equity Ratio0.55 Current Ratio2.48 Quick Ratio1.79 Sales & Book Value Annual Sales$509.79 million Price / Sales1.74 Cash Flow$1.04 per share Price / Cash Flow18.16 Book Value$5.46 per share Price / Book3.46Miscellaneous Outstanding Shares46,950,000Free Float46,593,000Market Cap$886.89 million OptionableOptionable Beta2.36 Social Links 7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed InvestorsAs the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.Get This Free Report This page (NYSE:CLB) was last updated on 11/2/2024 by MarketBeat.com Staff From Our PartnersMusk warns humanity: “Obsolete”The 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | SponsoredHow Will You Survive A Post Election Retirement Heist?The clock is ticking, and your life savings are in an extremely vulnerable position. We are a few days away...American Hartford Gold Group | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Core Laboratories Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Core Laboratories With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.